Skip to content

13F-HR filed by NEA Management Company, LLC

NEA Management Company, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 57 holding rows worth $2,003,435,000.

Accession
0001012975-22-000509
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 57 entries on the cover page, a total value of $2,003,435,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,003,435,000 with VALUE read as thousands by filing date, 13F file number 028-14302. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BRIGHT HEALTH GROUP INC10920V107COM218,212,126$229,123,000thousands by filing date
COURSERA INC COM22266M104Stock15,867,769$171,055,000thousands by filing date
IONQ INC COM46222L108Stock26,350,067$133,595,000thousands by filing date
ARCELLX INC COMMON STOCK03940C100Stock6,750,264$126,702,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM4,912,306$108,316,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock1,590,002$103,907,000thousands by filing date
CLOUDFLARE INC CL A COM18915M107Stock1,877,510$103,845,000thousands by filing date
ZEROFOX HLDGS INC98955G103COMMON18,090,861$88,283,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM4,187,801$87,986,000thousands by filing date
BERKSHIRE GREY INC084656107COM38,226,621$64,985,000thousands by filing date
MONTE ROSA THERAPEUTICS INC61225M102COM7,703,205$62,935,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS5,584,753$57,076,000thousands by filing date
NKARTA INC65487U108COMMON STOCK3,571,640$47,003,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock3,467,406$41,540,000thousands by filing date
GERON CORP374163103COM16,318,681$38,186,000thousands by filing date
SAVARA INC805111101COM24,137,931$37,414,000thousands by filing date
DESKTOP METAL INC25058X105COM CL A14,407,594$37,316,000thousands by filing date
ALLAKOS INC01671P100COM6,148,704$33,867,000thousands by filing date
OYSTER POINT PHARMA INC69242L106COMMON STOCK5,925,287$33,300,000thousands by filing date
AVEO PHARMACEUTICALS INC053588307COM3,952,957$32,533,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock3,969,834$29,853,000thousands by filing date
AKOUOS INC00973J101COM4,298,488$29,058,000thousands by filing date
BUZZFEED INC CL A NEW12430A102Stock15,333,892$23,921,000thousands by filing date
CVRX INC126638105COMMON STOCK2,370,858$22,120,000thousands by filing date
NEXTNAV INC65345N106COMMON STOCK8,189,156$22,029,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM3,685,683$21,451,000thousands by filing date
INVENTIVA SA46124U107ADS5,572,953$19,907,000thousands by filing date
SATSUMA PHARMACEUTICALS INC80405P107COM3,142,958$18,858,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR17,082,612$18,364,000thousands by filing date
TREVI THERAPEUTICS INC COM89532M101Stock11,373,174$17,515,000thousands by filing date
RENEO PHARMACEUTICALS INC75974E103COM4,786,921$16,036,000thousands by filing date
CHAMPIONS ONCOLOGY INC15870P307COM NEW1,713,720$12,853,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM6,523,157$11,155,000thousands by filing date
AFFIMED N VN01045108COM4,426,488$9,119,000thousands by filing date
FiscalNote Holdings Inc337655104Common Stock1,694,323$8,634,000thousands by filing date
BILL HOLDINGS INC090043100COM66,100$8,312,000thousands by filing date
Senti Biosciences, Inc.81726A100Common Stock4,429,725$8,233,000thousands by filing date
MINERVA SURGICAL INC60343F106COM10,001,937$7,956,000thousands by filing date
INOZYME PHARMA INC45790W108COM2,444,379$6,551,000thousands by filing date
BLACK DIAMOND THERAPEUTICS I09203E105COM3,449,845$5,830,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK2,382,286$5,717,000thousands by filing date
XERIS BIOPHARMA HOLDINGS INC98422E103COM3,246,785$5,065,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM9,089,041$5,014,000thousands by filing date
EARGO INC270087109COM4,520,849$4,747,000thousands by filing date
Tuya Inc90114C107COM4,934,640$4,588,000thousands by filing date
SYNLOGIC INC87166L100COM4,229,410$4,018,000thousands by filing date
MARKER THERAPEUTICS INC57055L107COM10,714,285$3,951,000thousands by filing date
MEI PHARMA INC55279B202COM NEW8,533,072$3,299,000thousands by filing date
AIRSPAN NETWORKS HOLDINGS IN00951K104COM1,534,633$3,100,000thousands by filing date
REGULUS THERAPEUTICS INC75915K200COM NEW1,445,115$2,457,000thousands by filing date
WHEELS UP EXPERIENCE I F96328L106Com1,061,259$1,220,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM6,643,702$1,169,000thousands by filing date
ADDEX THERAPEUTICS LTD00654J107SPONSORED ADS5,648,690$830,000thousands by filing date
ObsEva SAH5861P103COM4,586,563$652,000thousands by filing date
TRACON PHARMACEUTICALS INC89237H209COM NEW346,719$579,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR452,167$285,000thousands by filing date
PALO ALTO NETWORKS INC697435105COM141$22,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-22-000509this filing2022-11-14acceptance time not in the bulk data set